Investor Announcements - 2016

Pages:

TR-1 notification of major interest in shares

21^st Mar 2016

Second Price Monitoring Extension

17^th Mar 2016

Notice of Results

17^th Mar 2016

EKF Diagnostics Holdings plc announces Notice of Results.

Trading update

3^rd Feb 2016

EKF Diagnostics Holdings plc announces a trading update for the year ended 31 December 2015.

TR-1 notification of major interest in shares

20^th Jan 2016

TR-1 notification of major interest in shares

18^th Jan 2016

TR-1 notification of major interest in shares

15^th Jan 2016

Pages:

Archive

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.